Boston Scientific (NY:BSX)

42.60 -0.63 (-1.46%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9

...

30 31 Next >

Deadline Approaching: Boston Scientific Corporation (BSX) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

March 11, 2026

From Law Offices of Howard G. Smith

Via Business Wire

1 Profitable Stock to Research Further and 2 Facing Challenges

March 11, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...

Via StockStory

BOSTON SCIENTIFIC ALERT: Bragar Eagel & Squire, P.C. is Investigating Boston Scientific Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

March 10, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX

March 10, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Concealing Unsustainable U.S. Electrophysiology Segment Growth Rate: Levi & Korsinsky

March 10, 2026

From Levi & Korsinsky, LLP

Via Business Wire

The $2.5 Trillion Tsunami: Why 2026 has Become the Year of the Megadeal

March 10, 2026

As of March 10, 2026, the United States financial markets are witnessing an unprecedented explosion in Mergers and Acquisitions (M&A) that has caught even the most optimistic analysts by surprise....

Via MarketMinute

Law Offices of Frank R. Cruz Encourages Boston Scientific Corporation (BSX) Shareholders To Inquire About Securities Fraud Class Action

March 10, 2026

From Law Offices of Frank R. Cruz

Via Business Wire

Important Notice to Long-Term Shareholders of Boston Scientific Corporation (NYSE: BSX): Corcept Therapeutics, Inc. (NASDAQ: CORT); Nektar Therapeutics (NASDAQ: NKTR): and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims

March 10, 2026

From Grabar Law Office

Via GlobeNewswire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX)

March 10, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

The 2026 M&A Resurgence: Private Equity Confidence Hits Record Highs

March 09, 2026

The U.S. Mergers and Acquisitions (M&A) landscape has entered a blistering new phase of activity, shaking off the volatility of the mid-2020s to reach levels of engagement not seen in over half a...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm, Encourages Boston Scientific Corporation (BSX) Shareholders to Inquire About Securities Fraud Class Action

March 09, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

BSX Investors Have Opportunity to Join Boston Scientific Corporation Fraud Investigation with the Schall Law Firm

March 08, 2026

From The Schall Law Firm

Via Business Wire

Law Offices of Howard G. Smith Encourages Boston Scientific Corporation (BSX) Shareholders To Inquire About Securities Fraud Class Action

March 06, 2026

From Law Offices of Howard G. Smith

Via Business Wire

BOSTON SCIENTIFIC CORPORATION (BSX) INVESTOR ALERT Investors With Large Losses in Boston Scientific Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights

March 06, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

BSX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026

March 06, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

Rosen Law Firm Urges Boston Scientific Corporation (NYSE: BSX) Stockholders to Contact the Firm for Information About Their Rights

March 06, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

Investor Notice: Robbins LLP Informs Investors of the Boston Scientific Corporation Class Action Lawsuit

March 05, 2026

From Robbins LLP

Via Business Wire

3 Reasons Boston Scientific Stock Could Quietly 5X as the World Ages ↗

March 05, 2026

The beaten-down company is worth considering amid a major demographic shift underway now.

Via The Motley Fool

1 Healthcare Stock to Target This Week and 2 Facing Challenges

March 04, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have...

Via StockStory

Topics Retirement

Which S&P500 stocks are gapping on Wednesday? ↗

March 04, 2026

Via Chartmill

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific Corporation - BSX

March 03, 2026

From Pomerantz LLP

Via GlobeNewswire

Boston Scientific (BSX): Buy, Sell, or Hold Post Q4 Earnings?

March 02, 2026

What a brutal six months it’s been for Boston Scientific. The stock has dropped 29% and now trades at $76.39, rattling many shareholders. This might have inv...

Via StockStory

1 Oversold Stock Ready to Bounce Back and 2 Facing Challenges

March 01, 2026

Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.

Via StockStory

The 7,800 Frontier: Morgan Stanley Flips the Script with Bullish S&P 500 Forecast

February 27, 2026

In a dramatic departure from his historically cautious stance, Mike Wilson, Chief U.S. Equity Strategist at Morgan Stanley (NYSE: MS), has stunned Wall Street by raising the firm’s 12-month S&P 500...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Q4 Earnings Highlights: Boston Scientific (NYSE:BSX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks

February 25, 2026

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Boston Scientific (NYSE:BSX)...

Via StockStory

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific Corporation - BSX

February 24, 2026

From Pomerantz LLP

Via GlobeNewswire

The Great Unlocking: Medtronic’s Strategic Pivot and the MiniMed Spin-Off

February 24, 2026

Date: February 24, 2026 By: Financial Research Analyst Introduction For years, Medtronic plc (NYSE: MDT) was viewed by Wall Street as a reliable but sluggish giant—a "Dividend Aristocrat" that offered...

Via Finterra

Topics Artificial Intelligence Economy Initial Public Offering

Medtronic Hits 10-Quarter High: PFA Dominance and Robotic Surges Signal a New Era for MedTech

February 23, 2026

In a definitive sign that the medical technology sector has moved past its post-pandemic stagnation, Medtronic (NYSE: MDT) reported its strongest enterprise revenue growth in ten quarters for the third...

Via MarketMinute

Topics Artificial Intelligence Earnings Economy

Movers and shakers in today's after-hours session for S&P500 stocks? ↗

February 20, 2026

Via Chartmill

ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing ↗

February 20, 2026

Terns Pharmaceuticals has delivered a significant rally over the past year, lifting expectations around its clinical pipeline. The latest filing shifts attention to upcoming data and the company’s...

Via The Motley Fool

Topics Regulatory Compliance

< Previous 1 2 3 4 5 6 7 8 9

...

30 31 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.